Next |
home / stock / abt / abt message board
Subject | By | Source | When |
---|---|---|---|
$ABT 1Q23 CC transcript: | DewDiligence | investorshub | 04/20/2023 3:39:39 PM |
$ABT 1Q23 Results by Business Segment | DewDiligence | investorshub | 04/19/2023 3:45:11 PM |
$ABT reports 1Q23 resultsslightly increases 2023 guidance: | DewDiligence | investorshub | 04/19/2023 3:44:34 PM |
whytestocks: $ABT News Article - Abbott Laboratories (NYSE: ABT) is a Leading Gainer in Wednesday Mo | whytestocks | investorshangout | 04/19/2023 3:35:46 PM |
FreeStyle Libre gets expanded Medicare coverage: | DewDiligence | investorshub | 04/17/2023 4:17:29 PM |
FDA clears $ABT's standalone glucose reader from FreestyleLibre: | DewDiligence | investorshub | 04/14/2023 2:06:15 PM |
FDA enables integration of FreeStyle Libre with automated insulin delivery syste | DewDiligence | investorshub | 03/06/2023 5:20:07 PM |
$ABT TriClip (tricuspid-value clip) highlighted at ACC | DewDiligence | investorshub | 03/06/2023 1:15:06 AM |
$ABT acquires CSII for $20/sh casha 50% premium | DewDiligence | investorshub | 02/08/2023 11:23:33 PM |
$ABT reports 4Q22 resultsissues 2023 guidance: | DewDiligence | investorshub | 01/25/2023 1:58:21 PM |
$ABT CEO at$ JPM: Libre will become a | DewDiligence | investorshub | 01/10/2023 5:23:24 PM |
$ABT increases dividend for 51st(!) consecutive year: | DewDiligence | investorshub | 12/09/2022 6:34:55 PM |
$ABT 3Q22 CC transcript: | DewDiligence | investorshub | 10/19/2022 11:34:13 PM |
Yes sir Dew, I was nit taking a | wiwineguy | investorshub | 10/19/2022 1:57:13 PM |
From my post earlier today: The stock is | DewDiligence | investorshub | 10/19/2022 1:52:55 PM |
And yet its selling off like crazy | wiwineguy | investorshub | 10/19/2022 1:47:41 PM |
$ABT 3Q22 Results by Business Segment | DewDiligence | investorshub | 10/19/2022 1:31:25 PM |
$ABT reports 3Q22 resultsraises 2022 EPS guidance: | DewDiligence | investorshub | 10/19/2022 1:30:52 PM |
$ABTs TCT presentations: | DewDiligence | investorshub | 09/19/2022 12:12:53 AM |
$ABT 2Q22 CC transcript: | DewDiligence | investorshub | 07/20/2022 4:54:05 PM |
News, Short Squeeze, Breakout and More Instantly...
Abbott Laboratories Company Name:
ABT Stock Symbol:
NYSE Market:
2024-04-28 07:45:00 ET Finding "forever" stocks isn't easy. Corporations that can thrive and pay dividends for long periods are rare, but they do exist. Such companies tend to have several qualities, including competitive advantages and leadership in industries that are likely to continue g...
NORTHAMPTON, MA / ACCESSWIRE / April 23, 2024 / Abbott Eleven new HeartMates with 11 inspiring stories recognized at Abbott HeartMates Draft Day event in NYC. Abbott Just a week before the pro football draft, Abbott held a high-profile draft day experience for our HeartMates program. Hos...
2024-04-18 23:00:03 ET Lee Hambright from Bernstein issued a price target of $133.00 for ABT on 2024-04-18 21:44:00. The adjusted price target was set to $133.00. At the time of the announcement, ABT was trading at $105.27. The overall price target consensus is at $129.8...